V Square Quantitative Management LLC Takes Position in McKesson Corporation $MCK

11 Apr 2026, 11:54 by Danessa Lincoln · The Markets Daily

V Square Quantitative Management LLC bought a new stake in shares of McKesson Corporation (NYSE:MCK – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 711 shares of the company’s stock, valued at approximately $583,000.

Other institutional investors have also recently modified their holdings of the company. GGM Financials LLC bought a new stake in shares of McKesson during the 3rd quarter valued at $25,000. State of Wyoming acquired a new position in shares of McKesson during the 2nd quarter worth $29,000. Hopwood Financial Services Inc. acquired a new position in shares of McKesson during the 3rd quarter worth $31,000. Board of the Pension Protection Fund acquired a new position in shares of McKesson during the 4th quarter worth $33,000. Finally, Vermillion & White Wealth Management Group LLC acquired a new position in shares of McKesson during the 3rd quarter worth $33,000. 85.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, EVP Leann B. Smith sold 190 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 3,592 shares of company stock worth $3,518,555. Corporate insiders own 0.08% of the company’s stock.

Wall Street Analyst Weigh In

MCK has been the subject of a number of research analyst reports. Wells Fargo & Company boosted their price target on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Morgan Stanley reissued an “overweight” rating and set a $966.00 price target on shares of McKesson in a report on Thursday, January 29th. Leerink Partners reissued an “outperform” rating and set a $1,085.00 price target on shares of McKesson in a report on Thursday, March 5th. Robert W. Baird set a $968.00 price target on McKesson in a report on Wednesday, January 14th. Finally, Bank of America lowered their price target on McKesson from $1,040.00 to $1,000.00 and set a “buy” rating for the company in a report on Monday, April 6th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and an average price target of $970.93.

View Our Latest Report on MCK

McKesson Trading Down 0.8%

Shares of MCK stock opened at $866.02 on Friday. The stock has a market cap of $106.08 billion, a price-to-earnings ratio of 24.91, a PEG ratio of 1.26 and a beta of 0.42. The stock has a 50-day moving average of $916.22 and a 200-day moving average of $850.46. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00.

McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were paid a $0.82 dividend. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is presently 9.43%.

McKesson Company Profile

(Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.